Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors.

P E Heudel, A de Montfort, D Debieuvre, C Chouaid,M Carton,C Audigier-Valette,T Filleron,S Chabaud, A Stancu,X Quantin,S Hiret,L Bosquet,J Y Blay

Lung cancer (Amsterdam, Netherlands)（2023）

引用 0|浏览5

暂无评分

摘要

Treatment with ICI in AMLC patients was associated with a significantly reduced risk of SPC. Prospective studies are required to confirm these results.

查看译文

关键词

Second primary cancer,Lung cancer,Immunotherapy,Immune check points inhibitors,Second malignant neoplasia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要